Mikael Brink

1.3k total citations
29 papers, 897 citations indexed

About

Mikael Brink is a scholar working on Rheumatology, Radiology, Nuclear Medicine and Imaging and Immunology. According to data from OpenAlex, Mikael Brink has authored 29 papers receiving a total of 897 indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Rheumatology, 18 papers in Radiology, Nuclear Medicine and Imaging and 6 papers in Immunology. Recurrent topics in Mikael Brink's work include Rheumatoid Arthritis Research and Therapies (20 papers), Monoclonal and Polyclonal Antibodies Research (18 papers) and Systemic Lupus Erythematosus Research (13 papers). Mikael Brink is often cited by papers focused on Rheumatoid Arthritis Research and Therapies (20 papers), Monoclonal and Polyclonal Antibodies Research (18 papers) and Systemic Lupus Erythematosus Research (13 papers). Mikael Brink collaborates with scholars based in Sweden, Netherlands and France. Mikael Brink's co-authors include Solbritt Rantapää‐Dahlqvist, Johan Rönnelid, Lars Klareskog, Rikard Holmdahl, Monika Hansson, Leendert A. Trouw, Marije K. Verheul, Per‐Johan Jakobsson, René E. M. Toes and Göran Hallmans and has published in prestigious journals such as The American Journal of Human Genetics, Annals of the Rheumatic Diseases and Vaccine.

In The Last Decade

Mikael Brink

25 papers receiving 883 citations

Peers

Mikael Brink
Cristina Tommasi Italy
Kristi A. Koelsch United States
Felipe Andrade Brazil
Daiju Iwata Japan
Ferdinand C. Breedveld Netherlands
Schwartz Rs United States
Torsten Witte Germany
Silvia N. Kariuki United States
Susanna Brauner Sweden
H Einarsdottir Iceland
Cristina Tommasi Italy
Mikael Brink
Citations per year, relative to Mikael Brink Mikael Brink (= 1×) peers Cristina Tommasi

Countries citing papers authored by Mikael Brink

Since Specialization
Citations

This map shows the geographic impact of Mikael Brink's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mikael Brink with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mikael Brink more than expected).

Fields of papers citing papers by Mikael Brink

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mikael Brink. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mikael Brink. The network helps show where Mikael Brink may publish in the future.

Co-authorship network of co-authors of Mikael Brink

This figure shows the co-authorship network connecting the top 25 collaborators of Mikael Brink. A scholar is included among the top collaborators of Mikael Brink based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mikael Brink. Mikael Brink is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Brink, Mikael, Lotta Ljung, Monika Hansson, et al.. (2022). Anti-citrullinated protein antibody specificities and pulmonary fibrosis in relation to genetic loci in early rheumatoid arthritis. Lara D. Veeken. 61(12). 4985–4990. 4 indexed citations
2.
3.
Terao, Chikashi, Boel Brynedal, Xia Jiang, et al.. (2019). Distinct HLA Associations with Rheumatoid Arthritis Subsets Defined by Serological Subphenotype. The American Journal of Human Genetics. 105(3). 616–624. 30 indexed citations
4.
Brink, Mikael, Anders Lundquist, Andrey Alexeyenko, Kristina Lejon, & Solbritt Rantapää‐Dahlqvist. (2019). Protein profiling and network enrichment analysis in individuals before and after the onset of rheumatoid arthritis. Arthritis Research & Therapy. 21(1). 288–288. 17 indexed citations
5.
6.
Johansson, Linda, Lisbeth Ärlestig, Heidi Kokkonen, Mikael Brink, & Solbritt Rantapää‐Dahlqvist. (2017). An increased concentration of receptor activator of nuclear factor kappa-B ligand pre-dates the onset of rheumatoid arthritis. Lara D. Veeken. 56(12). 2190–2196. 10 indexed citations
7.
Brink, Mikael, Monika Hansson, Martin Cornillet, et al.. (2017). SAT0065 Acpa against different citrullinated peptides identify specific phenotypes of rheumatoid arthritis. Annals of the Rheumatic Diseases. 76. 792–792. 26 indexed citations
8.
Johansson, Linda, Federico Pratesi, Mikael Brink, et al.. (2016). Antibodies directed against endogenous and exogenous citrullinated antigens pre-date the onset of rheumatoid arthritis. Arthritis Research & Therapy. 18(1). 127–127. 44 indexed citations
9.
Brink, Mikael, Monika Hansson, Linda Mathsson‐Alm, et al.. (2016). Rheumatoid factor isotypes in relation to antibodies against citrullinated peptides and carbamylated proteins before the onset of rheumatoid arthritis. Arthritis Research & Therapy. 18(1). 43–43. 53 indexed citations
10.
Brink, Mikael, Marije K. Verheul, Johan Rönnelid, et al.. (2015). Anti-carbamylated protein antibodies in the pre-symptomatic phase of rheumatoid arthritis, their relationship with multiple anti-citrulline peptide antibodies and association with radiological damage. Arthritis Research & Therapy. 17(1). 25–25. 108 indexed citations
11.
Kokkonen, Heidi, Mikael Brink, Monika Hansson, et al.. (2015). Associations of antibodies against citrullinated peptides with human leukocyte antigen-shared epitope and smoking prior to the development of rheumatoid arthritis. Arthritis Research & Therapy. 17(1). 39 indexed citations
12.
Bokarewa, Maria, Mikael Brink, Malin C. Erlandsson, & Solbritt Rantapää‐Dahlqvist. (2014). Survivin but not Fms-like tyrosine kinase 3 ligand is up-regulated before the onset of rheumatoid arthritis: a pilot study. Arthritis Research & Therapy. 16(1). R45–R45. 20 indexed citations
13.
Brink, Mikael, et al.. (2013). Survivin But Not Fms-Like Tyrosine Kinase Ligand Is Up-Regulated Before Onset Of Rheumatoid Arthritis. Arthritis & Rheumatism. 65. 1 indexed citations
14.
Brink, Mikael, et al.. (2013). B-Regulatory-, CD19(+)CD20(+) CD24(high)CD38(high) -Cells Are Functionally Impaired In Patients With Rheumatoid Arthritis and Healthy First Degree Relatives Compared With Controls. Arthritis & Rheumatism. 65.
15.
Brink, Mikael, Monika Hansson, Linda Mathsson, et al.. (2013). Multiplex Analyses of Antibodies Against Citrullinated Peptides in Individuals Prior to Development of Rheumatoid Arthritis. Arthritis & Rheumatism. 65(4). 899–910. 159 indexed citations
16.
Lübbers, Joyce, Mikael Brink, Lotte A van de Stadt, et al.. (2013). The type I IFN signature as a biomarker of preclinical rheumatoid arthritis. Annals of the Rheumatic Diseases. 72(5). 776–780. 120 indexed citations
17.
Ärlestig, Lisbeth, Mikael Brink, Monika Hansson, et al.. (2012). Single Nucleotide Polymorphisms within the HLA-DRB1 Gene in Relation to Antibodies Against Citrullinated Peptides in Individuals Prior to the Development of Rheumatoid Arthritis. Arthritis & Rheumatism. 64(10).
18.
Brink, Mikael, Johan Rönnelid, Monika Hansson, et al.. (2012). Antibodies against native collagen and citrullinated proteins precede the development of rheumatoid arthritis with a consecutive pattern. Annals of the Rheumatic Diseases. 71. A22–A22.
19.
Hu, Xiaolei, et al.. (2010). Enriched environment increases spinophilin mRNA expression and spinophilin immunoreactive dendritic spines in hippocampus and cortex. Neuroscience Letters. 476(2). 79–83. 15 indexed citations
20.
Pandya, Pankita H., Wilfred E. Marissen, Mikael Brink, et al.. (2008). First administration to humans of a monoclonal antibody cocktail against rabies virus: Safety, tolerability, and neutralizing activity. Vaccine. 26(47). 5922–5927. 98 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Cristina Tommasi Breakdown of academic impact, for papers by Kristi A. Koelsch Breakdown of academic impact, for papers by Felipe Andrade Breakdown of academic impact, for papers by Daiju Iwata Breakdown of academic impact, for papers by Ferdinand C. Breedveld Breakdown of academic impact, for papers by Schwartz Rs Breakdown of academic impact, for papers by Torsten Witte Breakdown of academic impact, for papers by Silvia N. Kariuki Breakdown of academic impact, for papers by Susanna Brauner Breakdown of academic impact, for papers by H Einarsdottir
Rankless by CCL
2026